GLPwatch
Victoza vs Wegovy
Drug comparison
Last updated 2026-05-28 15:46 UTCVictoza (liraglutide) and Wegovy (semaglutide) are both injectable medications made by Novo Nordisk. Victoza is approved to treat type 2 diabetes and reduce cardiovascular risk, while Wegovy is approved for obesity and cardiovascular risk reduction.
AI summary of the sources below.
| Victoza | Wegovy | |
|---|---|---|
| Active ingredient | liraglutide | semaglutide |
| Manufacturer | novo-nordisk | novo-nordisk |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes, cardiovascular risk reduction | obesity, cardiovascular risk reduction |
| Label updated | 2023-02-06 | 2026-05-05 |